BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4057330)

  • 1. Value of routine follow-up in patients treated for squamous cell carcinoma of the head and neck.
    Boysen M; Natvig K; Winther FO; Tausjö J
    J Otolaryngol; 1985 Aug; 14(4):211-4. PubMed ID: 4057330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of treatment results for oral tongue cancer.
    Sessions DG; Spector GJ; Lenox J; Haughey B; Chao C; Marks J
    Laryngoscope; 2002 Apr; 112(4):616-25. PubMed ID: 12150512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma.
    Temam S; Koka V; Mamelle G; Julieron M; Carmantrant R; Marandas P; Janot F; Bourhis J; Luboinski B
    Head Neck; 2005 Aug; 27(8):653-8. PubMed ID: 16035097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
    Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of treatment results for floor-of-mouth cancer.
    Sessions DG; Spector GJ; Lenox J; Parriott S; Haughey B; Chao C; Marks J; Perez C
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1764-72. PubMed ID: 11037841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery.
    Wong LY; Wei WI; Lam LK; Yuen AP
    Head Neck; 2003 Nov; 25(11):953-9. PubMed ID: 14603456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
    Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
    J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage.
    Al-Othman MO; Mendenhall WM; Amdur RJ
    Am J Otolaryngol; 2001; 22(6):387-90. PubMed ID: 11713722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
    Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
    Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planned postradiotherapy bilateral neck dissection for head and neck cancer.
    Somerset JD; Mendenhall WM; Amdur RJ; Villaret DB; Stringer SP
    Am J Otolaryngol; 2001; 22(6):383-6. PubMed ID: 11713721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cancer of the head and neck: surgical treatment of local and regional recurrence.
    Ridge JA
    Semin Oncol; 1993 Oct; 20(5):419-29. PubMed ID: 7692603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of neck treatment in patients with head and neck squamous cell carcinoma.
    Buck G; Huguenin P; Stoeckli SJ
    Head Neck; 2008 Jan; 30(1):50-7. PubMed ID: 17636542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers.
    Kupferman ME; Morrison WH; Santillan AA; Roberts D; Diaz EM; Garden AS; Weber R
    Cancer; 2007 May; 109(10):2052-7. PubMed ID: 17407106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.